The university is investing in IsoPlexis.

The intraocular lens developer has now raised more than $90m, after completing a series D round that included Johnson & Johnson and Medtronic.

The India-based drug developer will seek businesses specialising in generic products as it looks to expand its reach in Europe.

The company plans to float in July.

Tencent and JD.com have invested in an early-stage round for smart scale manufacturer Picooc.

Convergence Pharmaceuticals, spun out of GlaxoSmithKline, which still holds an 18% stake, is considering both London and New York for its initial public offering.

The venture capital firm has closed its oversubscribed third fund with commitments from Cisco, Red Hat and Capitol Broadcasting among others.

Pharmaceutical companies including Baxter, Biogen Idec and GlaxoSmithKline, through its SR One subsidiary, all backed the round, which also included funds from True Norths' parent company iPierian.

The Chinese company has invested $34m in Cardio3 in addition to forming a joint venture to commercialise a heart failure indicator.